Screener
Mirum Pharmaceuticals, Inc. MIRM Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Accounts payable | $23,427 | $9,614 |
| Holdback liabilities, current | 24,800 | — |
| Accrued expenses and other current liabilities | 174,561 | 196,185 |
| Total current liabilities | 222,788 | 205,799 |
| Operating lease liabilities, noncurrent | 10,465 | 7,516 |
| Convertible notes payable, net, noncurrent | 750,079 | 309,797 |
| Holdback liabilities, noncurrent | 61,154 | — |
| Other liabilities | 10,917 | 5,011 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s total current liabilities?
- Mirum Pharmaceuticals, Inc. (MIRM) reported total current liabilities of $222.79M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s total current liabilities changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s total current liabilities increased by 53.9% year-over-year, from $144.8M to $222.79M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s total current liabilities has grown at a 62.0% compound annual growth rate (CAGR), from $18.46M to $205.8M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Mirum Pharmaceuticals, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude